Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Forxiga Tablets 5mg, 10mgGeneral Drug Use-Results Study n in Chronic Kidney Disease (CKD) Patients

NCT05306210 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05306210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Forxiga Tablets 5mg, 10mgGeneral Drug Use-Results Study n in Chronic Kidney Disease (CKD) Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 12, 2022
Completion date
October 8, 2024
Enrollment
1,029 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease